04.03.2022 - VANCOUVER, British Columbia, March 04, 2022 (GLOBE NEWSWIRE) - Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. . Seite 1
Core One Labs Inc.: Core One Labs Provides Clarification on Trading Activity
Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62, WKN:A2P8K3) (the
Company or
Core One ). This news release is issued at the request of the Investment Industry Regulatory Organization of Canada (
IIROC ) and the Canadian Securities Exchange (
CSE ). Statements made in the news release issued by the Company on May 4, 2021 indicated that the Company had been made aware of potentially manipulative trading activity in its common shares. The news release issued on May 4, 2021 was not reviewed by IIROC or the CSE prior to dissemination, and to date the Company has not filed a formal complaint with any regulatory authority regarding this trading activity.